Sales 2024 * | - | Sales 2025 * | 1.04M 758K | Capitalization | 27.51M 19.99M |
---|---|---|---|---|---|
Net income 2024 * | -74M -53.79M | Net income 2025 * | -54M -39.25M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 26.4 x |
P/E ratio 2024 * |
-0.25
x | P/E ratio 2025 * |
-0.36
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.29% |
Latest transcript on Aptose Biosciences
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
1st Jan change | Capi. | |
---|---|---|
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |